Bortezomib enhances fatty liver preservation in Institut George Lopez-1 solution through adenosine monophosphate activated protein kinase and Akt/mTOR pathways
Article first published online: 16 OCT 2013
© 2013 Royal Pharmaceutical Society
Journal of Pharmacy and Pharmacology
Volume 66, Issue 1, pages 62–72, January 2014
How to Cite
Bejaoui, M., Zaouali, M. A., Folch-Puy, E., Pantazi, E., Bardag-Gorce, F., Carbonell, T., Oliva, J., Rimola, A., Abdennebi, H. B. and Roselló-Catafau, J. (2014), Bortezomib enhances fatty liver preservation in Institut George Lopez-1 solution through adenosine monophosphate activated protein kinase and Akt/mTOR pathways. Journal of Pharmacy and Pharmacology, 66: 62–72. doi: 10.1111/jphp.12154
- Issue published online: 17 DEC 2013
- Article first published online: 16 OCT 2013
- Manuscript Accepted: 5 SEP 2013
- Manuscript Received: 16 MAR 2013
- Ministerio de Sanidad y Consumo. Grant Numbers: PI081988, PI12/00519
- Ciber-EHD, Instituto Carlos III, Madrid
- CSIC. Grant Number: ICOOP-0005 project
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.